ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 114 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $501,000 | +54.6% | 169,369 | -17.0% | 0.05% | +37.8% |
| Q4 2018 | $324,000 | -66.0% | 203,969 | -21.3% | 0.04% | -30.2% |
| Q3 2018 | $954,000 | +38.5% | 259,169 | +6.5% | 0.05% | +55.9% |
| Q2 2018 | $689,000 | +79.9% | 243,369 | +82.9% | 0.03% | +47.8% |
| Q4 2017 | $383,000 | -73.1% | 133,058 | -58.0% | 0.02% | -76.3% |
| Q3 2017 | $1,423,000 | -20.0% | 316,900 | -18.2% | 0.10% | -16.4% |
| Q2 2017 | $1,778,000 | +52.1% | 387,258 | +39.5% | 0.12% | +84.1% |
| Q1 2017 | $1,169,000 | +34.1% | 277,700 | +31.6% | 0.06% | +21.2% |
| Q4 2016 | $872,000 | +160.3% | 211,027 | +410.4% | 0.05% | +188.9% |
| Q3 2016 | $335,000 | +280.7% | 41,348 | +266.0% | 0.02% | +260.0% |
| Q2 2016 | $88,000 | -30.7% | 11,298 | -12.6% | 0.01% | 0.0% |
| Q1 2015 | $127,000 | – | 12,927 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,733,815 | $81,081,000 | 11.64% |
| RTW INVESTMENTS, LP | 2,589,818 | $17,896,000 | 5.56% |
| DAFNA Capital Management LLC | 480,300 | $3,319,000 | 3.29% |
| DOHENY ASSET MANAGEMENT /CA | 510,125 | $3,525,000 | 1.83% |
| Sio Capital Management, LLC | 364,368 | $2,518,000 | 1.73% |
| TURNER INVESTMENTS LLC | 1,086,000 | $7,504,000 | 1.52% |
| Ghost Tree Capital, LLC | 300,000 | $2,073,000 | 0.93% |
| Rock Springs Capital Management LP | 1,125,000 | $7,774,000 | 0.63% |
| SENZAR ASSET MANAGEMENT, LLC | 619,000 | $4,277,290,000 | 0.62% |
| Point72 Asset Management, L.P. | 9,772,018 | $67,525,000 | 0.53% |